Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Phrenic neuropathy and diaphragm dysfunction in neuralgic amyotrophy.

van Alfen N, Doorduin J, van Rosmalen MHJ, van Eijk JJJ, Heijdra Y, Boon AJ, Gaytant MA, van den Biggelaar RJM, Sprooten RTM, Wijkstra PJ, Groothuis JT.

Neurology. 2018 Aug 28;91(9):e843-e849. doi: 10.1212/WNL.0000000000006076. Epub 2018 Jul 27.

PMID:
30054437
2.

Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol.

Koolen EH, van der Wees PJ, Westert GP, Dekhuijzen R, Heijdra YF, van 't Hul AJ.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 19;13:2237-2244. doi: 10.2147/COPD.S153992. eCollection 2018.

3.

The COPDnet integrated care model.

Koolen EH, van der Wees PJ, Westert GP, Dekhuijzen R, Heijdra YF, van 't Hul AJ.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 19;13:2225-2235. doi: 10.2147/COPD.S150820. eCollection 2018.

4.

Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient.

Workum JD, de Jong SW, Gresnigt MS, Becker KL, Pickkers P, van de Veerdonk FL, Heijdra YF, Kolwijck E.

Med Mycol Case Rep. 2018 Mar 7;21:4-7. doi: 10.1016/j.mmcr.2018.03.002. eCollection 2018 Sep.

5.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
6.

Obesity in COPD: Revealed and Unrevealed Issues.

Zewari S, Vos P, van den Elshout F, Dekhuijzen R, Heijdra Y.

COPD. 2017 Dec;14(6):663-673. doi: 10.1080/15412555.2017.1383978. Review.

PMID:
29210599
7.

Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial.

Duenk RG, Verhagen C, Bronkhorst EM, van Mierlo P, Broeders M, Collard SM, Dekhuijzen P, Vissers K, Heijdra Y, Engels Y.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 28;12:2795-2806. doi: 10.2147/COPD.S141974. eCollection 2017.

8.

Increased Platelet-Monocyte Interaction in Stable COPD in the Absence of Platelet Hyper-Reactivity.

Aleva FE, Temba G, de Mast Q, Simons SO, de Groot PG, Heijdra YF, van der Ven AJAM.

Respiration. 2018;95(1):35-43. doi: 10.1159/000480457. Epub 2017 Oct 12.

PMID:
29020675
9.

The effects of signal transducer and activator of transcription three mutations on human platelets.

Aleva FE, van de Veerdonk FL, Li Y, Tunjungputri RN, Simons S, De Groot PG, Netea MM, Heijdra YF, de Mast Q, van der Ven AJAM.

Platelets. 2018 Sep;29(6):602-609. doi: 10.1080/09537104.2017.1349309. Epub 2017 Sep 29.

PMID:
28960117
10.

Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.

Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ, Lammers E, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 20;12:2121-2128. doi: 10.2147/COPD.S140037. eCollection 2017.

11.

The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis.

Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, Doorduin J, Van Engelen BG, Kampelmacher MJ, Raaphorst J.

Respir Res. 2017 Jul 25;18(1):144. doi: 10.1186/s12931-017-0624-8.

12.

Respiratory function in facioscapulohumeral muscular dystrophy 1.

Wohlgemuth M, Horlings CGC, van der Kooi EL, Gilhuis HJ, Hendriks JCM, van der Maarel SM, van Engelen BGM, Heijdra YF, Padberg GW.

Neuromuscul Disord. 2017 Jun;27(6):526-530. doi: 10.1016/j.nmd.2017.03.008. Epub 2017 Mar 22.

PMID:
28416348
13.

Respiratory pattern in a FSHD pediatric population.

van Kernebeek CR, Seijger CGW, Goselink RJM, Heijdra YF, van Engelen BGM.

Respir Med. 2017 May;126:130-131. doi: 10.1016/j.rmed.2017.03.007. Epub 2017 Mar 7. No abstract available.

PMID:
28291574
14.

The view of pulmonologists on palliative care for patients with COPD: a survey study.

Duenk RG, Verhagen C, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:299-311. doi: 10.2147/COPD.S121294. eCollection 2017.

15.

[When is a venous blood gas analysis sufficient in the emergency department?]

van Exsel JA, Simons SO, Kramers C, Heijdra YF.

Ned Tijdschr Geneeskd. 2017;161:D785. Review. Dutch.

PMID:
28145212
16.

Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.

Peters JB, Boer LM, Molema J, Heijdra YF, Prins JB, Vercoulen JH.

Int J Behav Med. 2017 Aug;24(4):571-583. doi: 10.1007/s12529-016-9622-3.

17.

Consistency of medical record reporting of a set of indicators for proactive palliative care in patients with chronic obstructive pulmonary disease.

Duenk RG, Verhagen SC, Janssen MA, Dekhuijzen RP, Vissers KC, Engels Y, Heijdra Y.

Chron Respir Dis. 2017 Feb;14(1):63-71. doi: 10.1177/1479972316661922. Epub 2016 Nov 21.

18.

Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.

Geerdink JX, Simons SO, Pike R, Stauss HJ, Heijdra YF, Hurst JR.

Respir Res. 2016 Oct 28;17(1):140.

19.

Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study.

van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF.

NPJ Prim Care Respir Med. 2016 Oct 13;26:16054. doi: 10.1038/npjpcrm.2016.54.

20.

Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension.

Braam EA, Quanjel MJ, Van Haren-Willems JH, Van Oosterhout MF, Vink A, Heijdra YF, Kwakkel-van Erp JM.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):182-5.

PMID:
27537724
21.

Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.

Aleva FE, Voets LWLM, Simons SO, de Mast Q, van der Ven AJAM, Heijdra YF.

Chest. 2017 Mar;151(3):544-554. doi: 10.1016/j.chest.2016.07.034. Epub 2016 Aug 12. Review.

PMID:
27522956
22.

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1.

Seijger CG, Drost G, Posma JM, van Engelen BG, Heijdra YF.

PLoS One. 2016 Mar 25;11(3):e0152344. doi: 10.1371/journal.pone.0152344. eCollection 2016.

23.

Using the Lower Limit of Normal Instead of the Conventional Cutoff Values to Define Predictors of Pulmonary Function Impairment in Subjects With Chronic Heart Failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Respir Care. 2016 Feb;61(2):173-83. doi: 10.4187/respcare.04101. Epub 2015 Oct 20.

24.

Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol.

Rafiq R, Aleva FE, Schrumpf JA, Heijdra YF, Taube C, Daniels JM, Lips P, Bet PM, Hiemstra PS, van der Ven AJ, den Heijer M, de Jongh RT.

BMC Pulm Med. 2015 Sep 23;15:106. doi: 10.1186/s12890-015-0101-4.

25.

Serial pulmonary function tests to diagnose COPD in chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PR, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Transl Respir Med. 2014 Dec;2(1):12. Epub 2014 Sep 25.

26.

Pulmonary function impairment in patients with chronic heart failure: lower limit of normal versus conventional cutoff values.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2014 Jul-Aug;43(4):311-6. doi: 10.1016/j.hrtlng.2014.03.011.

PMID:
24992882
27.

Successful liver transplantation and long-term follow-up in a patient with MPI-CDG.

Janssen MC, de Kleine RH, van den Berg AP, Heijdra Y, van Scherpenzeel M, Lefeber DJ, Morava E.

Pediatrics. 2014 Jul;134(1):e279-83. doi: 10.1542/peds.2013-2732.

28.

PROLONG: a cluster controlled trial to examine identification of patients with COPD with poor prognosis and implementation of proactive palliative care.

Duenk RG, Heijdra Y, Verhagen SC, Dekhuijzen RP, Vissers KC, Engels Y.

BMC Pulm Med. 2014 Apr 2;14:54. doi: 10.1186/1471-2466-14-54.

29.

Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.

Sluga R, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, Schermer TR.

Prim Care Respir J. 2014 Mar;23(1):85-91. doi: 10.4104/pcrj.2014.00006.

30.

Non-resolving pneumonia in patient with obsessive--compulsive disorder.

Simons SO, Braam EA, de Boer RC, Looijen-Salamon M, Heijdra YF.

Thorax. 2014 Feb;69(2):193. doi: 10.1136/thoraxjnl-2013-203759. Epub 2013 Nov 1. No abstract available.

PMID:
24186920
31.

Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Pulm Pharmacol Ther. 2014 Aug;28(2):158-64. doi: 10.1016/j.pupt.2013.09.002. Epub 2013 Sep 25.

PMID:
24076367
32.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):388-9. doi: 10.1016/j.hrtlng.2013.07.003. No abstract available.

PMID:
23998386
33.

COPD in chronic heart failure: less common than previously thought?

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.

34.

Can COPD patients who hyperinflate during daily life activities be identified by laboratory tests?

Lahaije A, van Helvoort H, Dekhuijzen R, Heijdra Y.

Respiration. 2013;86(3):237-42. doi: 10.1159/000351108. Epub 2013 Aug 27.

35.

Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.

Barrera P, Simons SO, Luijk B, Wessels MJ, Heijdra YF.

Ann Am Thorac Soc. 2013 Aug;10(4):408-9. doi: 10.1513/AnnalsATS.201212-125OC. No abstract available.

PMID:
23952870
36.

Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial.

Charususin N, Gosselink R, Decramer M, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, van Helvoort H, Heijdra Y, Klaassen M, Glöckl R, Kenn K, Langer D.

BMJ Open. 2013 Aug 5;3(8). pii: e003101. doi: 10.1136/bmjopen-2013-003101.

37.

[Medicinal intervention for COPD; even in patients with mild or moderate COPD?].

Dekhuijzen PN, van Helvoort HA, Willems LM, Heijdra YF.

Ned Tijdschr Geneeskd. 2013;157(26):A5399. Review. Dutch.

PMID:
23835231
38.

The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Respir Med. 2013 Sep;107(9):1393-9. doi: 10.1016/j.rmed.2013.05.008. Epub 2013 Jun 12.

39.

The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.

van Dijk WD, Akkermans R, Heijdra Y, Weel Cv, Schermer TR, Scheepers PT, Lenders JW.

Biomark Med. 2013 Apr;7(2):211-9. doi: 10.2217/bmm.12.112.

PMID:
23547816
40.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 May-Jun;42(3):229-30. doi: 10.1016/j.hrtlng.2013.03.001. Epub 2013 Mar 22. No abstract available.

PMID:
23522807
41.

Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1.

Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF.

Respir Med. 2013 Jun;107(6):834-40. doi: 10.1016/j.rmed.2013.02.017. Epub 2013 Mar 17.

42.

An autonomous mobile system for the management of COPD.

van der Heijden M, Lucas PJ, Lijnse B, Heijdra YF, Schermer TR.

J Biomed Inform. 2013 Jun;46(3):458-69. doi: 10.1016/j.jbi.2013.03.003. Epub 2013 Mar 15.

43.

Short-acting anticholinergic bronchodilation does not increase cardiovascular events in smokers with mild to moderate pulmonary obstruction.

de Jong E, van Dijk WD, Heijdra Y, Lenders JW, van Weel C, Akkermans R, Schermer TR.

Respirology. 2013 May;18(4):663-8. doi: 10.1111/resp.12040.

PMID:
23278997
44.

Bronchodilator responsiveness in patients with chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 May-Jun;42(3):208-14. doi: 10.1016/j.hrtlng.2012.11.007. Epub 2012 Dec 27.

PMID:
23273658
45.

Diagnostic accuracy of metronome-paced tachypnea to detect dynamic hyperinflation.

Lahaije AJ, Willems LM, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF.

Clin Physiol Funct Imaging. 2013 Jan;33(1):62-9. doi: 10.1111/j.1475-097X.2012.01164.x. Epub 2012 Sep 2.

PMID:
23216767
46.

[Working with the Dutch Standard of Care for COPD: using the 'Nijmegen Clinical Screening Instrument' as an aid].

Vercoulen JH, Bischoff EW, Heijdra YF.

Ned Tijdschr Geneeskd. 2012;156(45):A4919. Dutch.

PMID:
23134747
47.

Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.

van Dijk WD, Heijdra Y, Lenders JW, Klerx W, Akkermans R, van der Pouw A, van Weel C, Scheepers PT, Schermer TR.

Respir Med. 2013 Jan;107(1):112-9. doi: 10.1016/j.rmed.2012.09.019. Epub 2012 Oct 12.

48.

Decline of health status sub-domains by exacerbations of chronic obstructive pulmonary disease: a prospective survey.

Verhage T, Boer L, Molema J, Heijdra Y, Dekhuijzen R, Vercoulen JH.

Respiration. 2013;85(3):236-43. doi: 10.1159/000339925. Epub 2012 Aug 22.

49.

Non-invasive ventilation abolishes the IL-6 response to exercise in muscle-wasted COPD patients: a pilot study.

Hannink JD, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF.

Scand J Med Sci Sports. 2014 Feb;24(1):136-43. doi: 10.1111/j.1600-0838.2012.01484.x. Epub 2012 Jun 19.

PMID:
22712527
50.

COPD Anno 2011: emphasis on bronch(iol)odilation.

Lahaije AJ, Heijdra YF, Willems LM, van Helvoort HA, Dekhuijzen PN.

J Aerosol Med Pulm Drug Deliv. 2012 Jun;25(3):148-53. doi: 10.1089/jamp.2011.0922. Review.

PMID:
22686624

Supplemental Content

Loading ...
Support Center